A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers

NCT03301870 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritation Potential of Topic Agent

Interventions

DRUG: ATx201 Gel 2%
DRUG: ATx201 Gel 4%
DRUG: Positive Control
DRUG: Negative Control
DRUG: ATx201 Placebo

Sponsor

UNION therapeutics